Literature DB >> 17460535

Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies.

Paul M Kemp1, Sandra A Hoffmann, Livia Tossici-Bolt, John S Fleming, Clive Holmes.   

Abstract

OBJECTIVE: To assess the utility of the appearances of occipital lobe perfusion on HMPAO SPECT in the diagnosis of dementia with Lewy bodies (DLB) using the 123I-FP-CIT findings as the diagnostic 'gold standard'.
METHODS: Eighty-four consecutive patients underwent both HMPAO SPECT and 123I-FP-CIT as part of their routine investigations for suspected DLB.
RESULTS: Thirty-nine of the 84 FP-CIT scans were abnormal indicating a prevalence of 44% of patients with DLB in this series. In those patients classified as DLB, 28% of HMPAO SPECT scans demonstrated occipital hypoperfusion. In those patients with a dementia other than DLB 31% of patients demonstrated occipital hypoperfusion (P=0.8).
CONCLUSION: Occipital lobe hypoperfusion as demonstrated by HMPAO SPECT in patients with suspected Lewy body dementia does not appear to be able to either rule in, or rule out, the diagnosis of DLB.

Entities:  

Mesh:

Year:  2007        PMID: 17460535     DOI: 10.1097/MNM.0b013e328155d143

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  9 in total

1.  Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?

Authors:  Tamara G Fong; Sharon K Inouye; Weiying Dai; Daniel Z Press; David C Alsop
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

2.  Cerebrospinal fluid biomarkers for dementia with lewy bodies.

Authors:  Elizabeta B Mukaetova-Ladinska; Rachael Monteith; Elaine K Perry
Journal:  Int J Alzheimers Dis       Date:  2010-10-17

3.  Differential diagnosis of dementia with Lewy Bodies and Alzheimer Disease using combined MR imaging and brain perfusion single-photon emission tomography.

Authors:  H Goto; K Ishii; T Uemura; N Miyamoto; T Yoshikawa; K Shimada; S Ohkawa
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

4.  Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life.

Authors:  Montserrat Estorch; Valle Camacho; Pilar Paredes; Elisabet Rivera; Ato Rodríguez-Revuelto; Albert Flotats; Jaume Kulisevsky; Ignasi Carrio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-29       Impact factor: 9.236

5.  Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis.

Authors:  Sean J Colloby; John-Paul Taylor; Christopher M Davison; Jim J Lloyd; Michael J Firbank; Ian G McKeith; John T O'Brien
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-30       Impact factor: 6.200

6.  Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study.

Authors:  John-Paul Taylor; Michael Firbank; Nicola Barnett; Sarah Pearce; Anthea Livingstone; Urs Mosimann; Janet Eyre; Ian G McKeith; John T O'Brien
Journal:  Br J Psychiatry       Date:  2011-10-20       Impact factor: 9.319

7.  Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study.

Authors:  John-Paul Taylor; Michael J Firbank; Jiabao He; Nicola Barnett; Sarah Pearce; Anthea Livingstone; Quoc Vuong; Ian G McKeith; John T O'Brien
Journal:  Br J Psychiatry       Date:  2012-04-12       Impact factor: 9.319

8.  Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences.

Authors:  Stefano Delli Pizzi; Raffaella Franciotti; John-Paul Taylor; Astrid Thomas; Armando Tartaro; Marco Onofrj; Laura Bonanni
Journal:  Cereb Cortex       Date:  2014-09-26       Impact factor: 5.357

9.  The cingulate island sign within early Alzheimer's disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer's disease from dementia with Lewy bodies.

Authors:  Etsuko Imabayashi; Kota Yokoyama; Tadashi Tsukamoto; Daichi Sone; Kaoru Sumida; Yukio Kimura; Noriko Sato; Miho Murata; Hiroshi Matsuda
Journal:  EJNMMI Res       Date:  2016-09-13       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.